HALEU Workshop Report AVAILABLE: High-Assay Low Enriched Uranium Demand and Deployment Options

June 20, 2020

Advanced reactors are being developed for flexible baseload power generation, providing US leadership in nuclear technology, enabling new markets for export, and reducing greenhouse gas emissions. Many of these reactors will require High-Assay Low-Enriched Uranium (HALEU) fuel, which is also used at a small scale for fueling research reactors and for medical isotope production facilities. There are currently no commercial suppliers of HALEU in the United States.

In April 2020, the Gateway for Advanced Innovation in Nuclear (GAIN), the Electric Power Research Institute (EPRI) and the Nuclear Energy Institute (NEI) held a virtual workshop on High-Assay Low-Enriched Uranium with the purpose of gathering a team of experts from across the national laboratories and industry to evaluate the anticipated demand for HALEU, the timing of that demand, and to evaluate the options for meeting that demand. The resulting High-Assay Low Enriched Uranium Demand and Deployment Options Report addresses findings and recommendations to meet HALEU demand.

Scroll to Top